Cargando…

Proton pump inhibitors and acute kidney injury: a nested case–control study

BACKGROUND: Proton pump inhibitors (PPI) are a widely-used class of drugs for the treatment of gastro-esophageal reflux disease and other acid-related disorders of the gastrointestinal tract. As a class, PPIs have demonstrated a favorable safety profile. However, case reports have suggested that thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klepser, Donald G, Collier, Dean S, Cochran, Gary L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717286/ https://www.ncbi.nlm.nih.gov/pubmed/23865955 http://dx.doi.org/10.1186/1471-2369-14-150

Ejemplares similares

Association of proton pump inhibitors and concomitant drugs with risk of acute kidney injury: a nested case–control study
por: Ikuta, Keiko, et al.
Publicado: (2021)

Proton pump inhibitors and risk of periampullary cancers—A nested case–control study
por: Chien, Li‐Nien, et al.
Publicado: (2015)

Association Between Cholangiocarcinoma and Proton Pump Inhibitors Use: A Nested Case-Control Study
por: Peng, Yen-Chun, et al.
Publicado: (2018)

Association between Proton Pump Inhibitors and Hearing Impairment: A Nested Case-Control Study
por: Kim, So Young, et al.
Publicado: (2021)

Proton pump inhibitors and the risk of hospital-acquired acute kidney injury in children
por: Li, Yanqin, et al.
Publicado: (2020)

Proton Pump Inhibitor Use is Associated With Risk of Pancreatic Cancer: A Nested Case–Control Study
por: Peng, Yen-Chun, et al.
Publicado: (2018)

Association between Urolithiasis and History Proton Pump Inhibitor Medication: A Nested Case-Control Study
por: Kim, So Young, et al.
Publicado: (2022)

A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use
por: Blank, Mei-Ling, et al.
Publicado: (2014)

No association between proton pump inhibitor use and ALS risk: a nationwide nested case–control study
por: Cetin, Hakan, et al.
Publicado: (2020)

Use of proton pump inhibitors and macrolide antibiotics and risk of acute kidney injury: a self-controlled case series study
por: Ikuta, Keiko, et al.
Publicado: (2022)

Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case–control study
por: Bradley, M C, et al.
Publicado: (2012)

Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies
por: Yang, Yi, et al.
Publicado: (2017)

Dose-Dependent Proton Pump Inhibitor Exposure and Risk of Type 2 Diabetes: A Nationwide Nested Case–Control Study
por: Kuo, Hsin-Ya, et al.
Publicado: (2022)

Proton-Pump Inhibitors and Hypomagnesaemia in Kidney Transplant Recipients
por: Douwes, Rianne M., et al.
Publicado: (2019)

Association between Proton Pump Inhibitor Use and the Risk of Female Cancers: A Nested Case-Control Study of 23 Million Individuals
por: Nguyen, Nhi Thi Hong, et al.
Publicado: (2022)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

A Meta-Analysis of Proton Pump Inhibitor Use and the Risk of Acute Kidney Injury: Geographical Differences and Associated Factors
por: Han, Cheng Ta, et al.
Publicado: (2023)

Proton Pump Inhibitors and Kidney Disease—GI Upset for the Nephrologist?
por: Toth-Manikowski, Stephanie M., et al.
Publicado: (2017)

The association between chronic rhinosinusitis and proton pump inhibitor use: a nested case–control study using a health screening cohort
por: Choi, Hyo Geun, et al.
Publicado: (2022)

Risk of Adverse Cardiovascular Events Following a Myocardial Infarction in Patients Receiving Combined Clopidogrel and Proton Pump Inhibitor Treatment: A Nested Case–Control Study
por: Farhat, Nawal, et al.
Publicado: (2020)

Proton pump inhibitors associated acute kidney injury and chronic kidney disease: data mining of US FDA adverse event reporting system
por: Wu, Bin, et al.
Publicado: (2021)

Acute interstitial nephritis due to proton pump inhibitors
por: Sampathkumar, K., et al.
Publicado: (2013)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Proton Pump Inhibitors, Kidney Damage, and Mortality: An Updated Narrative Review
por: Edinoff, Amber N., et al.
Publicado: (2023)

Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study
por: Arana, Alejandro, et al.
Publicado: (2015)

Associations between proton pump inhibitors and Alzheimer’s disease: a nested case–control study using a Korean nationwide health screening cohort
por: Choi, Hyo Geun, et al.
Publicado: (2022)

Prolonged Use of Proton Pump Inhibitors and Risk of Type 2 Diabetes: Results From a Large Population-Based Nested Case-Control Study
por: Ciardullo, Stefano, et al.
Publicado: (2022)

Association between Migraines and Prior Proton Pump Inhibitor Use: A Nested Case-Control Study Using a National Health Screening Cohort
por: Kang, Ho Suk, et al.
Publicado: (2022)

Diabetic Nephropathy and Proton Pump Inhibitors – Pilot Case-Control Study
por: Raj, Jeffrey Pradeep, et al.
Publicado: (2022)

Unusual Neurological Manifestation of Proton Pump Inhibitor: A Case Report of Acute Disseminated Encephalomyelitis and Severe Hyponatremia After Brief Use of Proton Pump Inhibitor
por: Qureshi, Ahmad S, et al.
Publicado: (2021)

A Case of Proton Pump Inhibitor-induced Fasciitis
por: Nakanishi, Yuki, et al.
Publicado: (2019)

An unusual case of proton pump inhibitor induced hyperchromograninemia
por: Adu-Gyamfi, Kwabena Oware, et al.
Publicado: (2019)

Proton-pump inhibitor omeprazole attenuates hyperoxia induced lung injury
por: Richter, Jute, et al.
Publicado: (2016)

Proton pump inhibitors are associated with increased risk of development of chronic kidney disease
por: Arora, Pradeep, et al.
Publicado: (2016)

Pharmacoepidemiology for nephrologists: do proton pump inhibitors cause chronic kidney disease?
por: Tomlinson, Laurie A., et al.
Publicado: (2017)

Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease
por: Hughes, John, et al.
Publicado: (2018)

The Effect of Proton Pump Inhibitor Use on Renal Function in Kidney Transplanted Patients
por: Flothow, Dominik J. G., et al.
Publicado: (2020)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_toj1e5c1dlaa77gfqeo7db8hsp